Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cardlytics Q1 2024 Adj EPS $(0.09) Beats $(0.11) Estimate, Sales $67.608M Miss $71.693M Estimate

Author: Benzinga Newsdesk | May 08, 2024 04:09pm
Cardlytics (NASDAQ:CDLX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by 18.18 percent. The company reported quarterly sales of $67.608 million which missed the analyst consensus estimate of $71.693 million by 5.70 percent. This is a 5.09 percent increase over sales of $64.331 million the same period last year.

Posted In: CDLX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist